Sarah A Carratt
9PUBLICATIONS
38CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Sep 19, 2024
An industry perspective on the FDA Modernization Act 2.0/3.0: potential next steps for sponsors to reduce animal use in drug development.Sarah A Carratt, Christina L Zuch de Zafra, Elias Oziolor
|May 01, 2024
The Vedotin Antibody-Drug Conjugate Payload Drives Platform-Based Nonclinical Safety and Pharmacokinetic Profiles.Haley D Neff-LaFord, Sarah A Carratt, Christopher Carosino
|Apr 28, 2022
Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms.Sarah A Carratt, Garth L Kong, Brittany M Curtiss
|May 18, 2021
Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.Sarah A Carratt, Theodore P Braun, Cody Coblentz
|Dec 01, 2019
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.Theodore P Braun, Mariam Okhovat, Cody Coblentz
Pageof 2
Frequent Collaborators
4 joint publications
Theodore P Braun
4 joint publications
Julia E Maxson
3 joint publications
Benjamin R Weeder
3 joint publications
Brian J Druker
3 joint publications
Brittany M Curtiss
2 joint publications
Kimberly Nevonen
2 joint publications
Brett Davis
2 joint publications
Shannon McWeeney
2 joint publications
Roy Drissen
2 joint publications
Claus Nerlov
